Bridging Artificial Intelligence and Wet Lab: a new era in Antibody Development

Webinar on demand

Monoclonal antibody-based therapies are expanding fast, driven by their tremendous therapeutic potential. In parallel, artificial intelligence is redefining the way antibodies are discovered and optimized—especially for complex targets such as Multi-Pass Membrane Proteins. When combined with wet lab expertise, AI plays a crucial role across all stages of development.

Replay Webinar Form

Your Speaker

karim MEF
Karim SEBANE, Ph.D., MBA
Account Manager I Monoclonal Antibodies
logo_bleu-300-1

What will you learn ?

  • The role of monoclonal antibodies and their main therapeutic applications
  • Key strategies to tackle complex targets, including Multi-Pass Membrane Proteins
  • How AI  is transforming antibody discovery, from screening to optimization
  • Why wet lab expertise remains indispensable in the AI era
  • Why the future is now: designing de novo antibodies directly in silico

Monoclonal antibody-based therapies are expanding fast, driven by their tremendous therapeutic potential. In parallel, artificial intelligence is redefining the way antibodies are discovered and optimized—especially for complex targets such as Multi-Pass Membrane Proteins. When combined with wet lab expertise, AI plays a crucial role across all stages of development.

What will you'll learn ?